A craft marijuana brand is turning a famous California winery into a Wonka Factory for weed
Visitors will eventually tour the facilities where small farmers test, dry, cure, trim, process, and package marijuana for distribution
Second-Hand Exposure of Staff Administering Vaporised Cannabinoid Products to Patients in a Hospital Setting
In many health settings, administration of medicinal cannabis poses significant implementation barriers including drug storage and safety for administering staff and surrounding patients. Different modes of administration also provide different yet potentially significant issues. One route that has become of clinical interest owing to the rapid onset of action and patient control of the inhaled amount (via breath timing and depth) is that of vaporisation of cannabinoid products. Although requiring a registered therapeutic device for administration, this is a relatively safe method of intrapulmonary administration that may be particularly useful for patients with difficulty swallowing, and for those in whom higher concentrations of cannabinoids are needed quickly. Research results are reassuring for hospital and clinical trial practices with staff administering vaporised cannabinoid products, and helpful to ethics committees wishing to quantify risk.
The role of cannabinoids in pain control: the good, the bad, and the ugly
Cannabinoids appear to possess many potential medical uses, which may extend to pain control. A narrative review of the literature has found a variety of studies testing botanical and synthetic cannabinoids in different pain syndromes (acute pain, cancer pain, chronic noncancer pain, fibromyalgia pain, migraine, neuropathic pain, visceral pain, and others). Results from these studies are mixed; cannabinoids appear to be most effective in controlling neuropathic pain, allodynia, medication-rebound headache, and chronic noncancer pain. A great deal more remains to be elucidated about cannabinoids which may emerge to play an important role in the treatment of neuropathic and possibly other painful conditions. There remains a great deal more to learn about the role of cannabinoids in pain management.
Why Germans love marijuana to kill pain
Germany’s medical marijuana users are people tired of popping powerful pills to ease pain. Facing a cannabis import crisis, the country is now starting to grow its own.
What’s the Safest Way to Consume Legal Cannabis? Experts Weigh In
For the thousands of Vermonters who choose to use recreationally, what will the equivalent of a “drink responsibly” campaign for cannabis look like? “Toke thoughtfully”? “Warning: Objects may appear more edible than they are”?
What’s in Your Weed? Touring Florida’s Marijuana Testing Lab
So how do you know exactly which herb will be the most beneficial for your ailment? How can Florida’s doctors, many of whom have never prescribed medical marijuana, know which strain, concentration, and dosage is right for their patients?
Aurora Exclusive Winner of First Italian Government Medical Cannabis Tender
While the Italian Ministry of Defence currently produces medical cannabis for the domestic market, certain wholesalers are permitted to purchase directly from the Dutch Office of Medical Cannabis, a sharp rise in demand has led to the government seeking external parties to provide additional supply.
Tennessee Lawmakers Propose Allowing Medical Cannabis — As Long As It’s Not Smoked
Two Republican lawmakers say they’re introducing a measure that would legalize oil-based marijuana products for patients with certain health conditions
US credit union offers banking services for medical cannabis businesses
A credit union in Maryland, USA, is offering banking services to support the state’s rising medical cannabis industry
Cannabis Use is Associated with Lower Odds of Prescription Opioid Analgesic Use Among HIV-Infected Individuals with Chronic Pain
We conducted a secondary data analysis of screening interviews conducted as part of a parent randomized trial of financial incentives to improve HIV outcomes among drug users. In a convenience sample of people with HIV and chronic pain, we collected self-report data on demographic characteristics. Our data suggest that new medical cannabis legislation might reduce the need for opioid analgesics for pain management, which could help to address adverse events associated with opioid analgesic use.